Relmada Therapeutics, Inc. (RLMD)

NasdaqCM • Currently down 0.49 (-15.76%) in today's trading session

Track congressional stock trades in Relmada Therapeutics, Inc. (RLMD). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Relmada Therapeutics, Inc. is currently trading at $2.62, positioned at 0% of its 52-week range ($2.60 – $8.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$2.62
24h Change
-0.49 (-15.76%)
52 Week Range
$2.60–$8.00
View on NASDAQ

Relmada Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for RLMD

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$279.54M

Volume

2.25M

Beta

0.45

P/E Ratio

-2.91

Fundamentals

EPS

$-0.90

Div. Yield

-

Open

$3.04

Day Range

$2.60 – $3.13

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Sergio Traversa
IPO Date
2014-06-20

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clin...

Earnings

Next Report

Q4 2026

18 Mar

EPS Est.

$-0.12

Rev. Est.

-

Days Until

116

Recent Quarters

Q3 202612 Nov
EPS$-0.12
Beat 17.2%
Q2 20266 Aug
EPS$-0.11
Beat 44.9%
Q1 202612 May
EPS$-0.22
Miss 22.2%
Q4 202519 Mar
EPS$-0.27
Miss 92.9%
Q3 202513 Nov
EPS$-0.30
Miss 650.0%
Q2 20257 Aug
EPS$-0.30
Miss 20.0%
Q1 202512 May
EPS$-0.58
Miss 87.1%
Q4 202427 Mar
EPS$-0.62
Beat 11.4%
Q3 20247 Nov
EPS$-0.72
Miss 10.8%
Q2 20247 Aug
EPS$-0.59
Beat 28.9%
Q1 20248 May
EPS$-0.72
Beat 20.0%
Q4 202319 Mar
EPS$-0.84
Beat 4.5%
Q3 20238 Nov
EPS$-0.73
Beat 23.2%
Q2 20238 Aug
EPS$-0.84
Beat 8.7%
Q1 202311 May
EPS$-0.87
Beat 1.1%
Q4 202223 Mar
EPS$-1.26
Beat 5.3%
Q3 202210 Nov
EPS$-1.31
Beat 6.4%
Q2 202211 Aug
EPS$-1.33
Miss 2.3%
Q1 20225 May
EPS$-1.40
Miss 15.7%
Q4 202123 Mar
EPS$-1.80
Miss 12.5%
Q3 202111 Nov
EPS$-2.44
Miss 50.6%
Q2 202110 Aug
EPS$-1.56
Miss 6.1%
Q1 202112 May
EPS$-1.34
Beat 3.6%
Q4 202023 Mar
EPS$-1.28
Miss 15.3%
Q3 202012 Nov
EPS$-1.05
Miss 22.1%
Q2 202012 Aug
EPS$-0.73
Miss 32.7%
Q1 202015 May
EPS$-0.72
Miss 118.2%
Q4 201926 Mar
EPS$-0.39
Miss 8.3%
Q3 201913 Nov
EPS$-0.38
Q2 201924 Sept
EPS$-0.44
Q1 201914 May
EPS$-0.36
Q4 201813 Feb
EPS$-1.12
Q3 201813 Nov
EPS$-1.08
Q2 201828 Sept
EPS$-1.07
Q1 201814 May
EPS$-1.04
Q4 201712 Feb
EPS$-0.44
Q3 201714 Nov
EPS$-0.32
Q2 201728 Sept
EPS$-0.52
Q1 201715 May
EPS$-0.66
Q4 201610 Feb
EPS$-0.34
Q3 201610 Nov
EPS$-0.55
Q2 201612 Sept
EPS$-1.16
Miss 70.6%
Q1 20169 May
EPS$-0.60
Beat 61.5%
Q4 20155 Feb
EPS$-0.88
Beat 47.6%
Q3 20156 Nov
EPS$0.36
Q2 201511 Sept
EPS$-6.12
Miss 1600.0%
Q1 201519 May
EPS$-0.92
Q4 201413 Feb
EPS$1.55
Q3 20147 Nov
EPS$-14.65
Q2 201415 Aug
EPS$-0.00
Q1 201430 Jun
EPS$-25.06
Q4 201310 Jan
EPS$-0.01
Q3 201316 Dec
EPS$-0.10
Q2 201312 Jul
EPS$-0.01
Q1 20133 May
EPS$-0.00
Q3 201230 Nov
EPS$-0.01
Q2 201231 Aug
EPS$-0.00
Q1 201231 May
EPS$-0.00
Q4 201129 Feb
EPS$-0.00

No dividend data available for this stock.

Stock Splits

Split History

30 Sept 2019Reverse Split
Ratio1:4
12 Aug 2015Reverse Split
Ratio1:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.